Health Care · Medicinal Chemicals & Botanical Products · OTC · CIK 1756390 · FYE Dec 31 · Prices AT CLOSE 2026-08-21 (USD) Last $0.48 · Day +5.47% · Mkt cap $98M · 1Y −27.3% · Off 52W high −60.0% · Vol (1Y) 123.7% Price2023-08-21 → 2026-08-21 AAWH close: $0.55 on 2023-08-21 to $0.48 on 2026-08-21. Split-adj closes · 240 of 1,281 · price returnⓘ At a glance | Short interest0.0% of sh out | | Days to cover1.0d | | Next report (est.)2026-11-11 |
SI 2026-07-31ⓘ Key fundamentalsFY 2025 | Sales (TTM)$488.3M | | Earnings (TTM)-$113.8M | | Net margin−23.6% | | ROIC−6.1% | | Total debt / EBITDA5.33× | | Sales growth 3Y7.2% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−33.8% | | 1Y−27.3% | | 3Y−13.4% | | 5Y−95.4% | | Since incept. (ann.)−45.4% |
Total return · from 2021-07-15ⓘ Risk | Ann. volatility (1Y)123.7% | | Ann. volatility (3Y)104.7% | | Sharpe (1Y)0.46 | | Sharpe (3Y)0.47 | | Max drawdown (1Y)−65.0% | | Max drawdown (3Y)−83.8% | | Beta (3Y vs SPY)−0.35 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 No 13F holders on file for AAWH. Latest reported quarterslast report 2026-08-12 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-12 | −$0.05 | — | $126.1M | −0.9% | | 2026-03-31 | 2026-05-13 | −$0.15 | — | $116.9M | −8.6% | | 2025-12-31 | 2026-03-12 | — | — | $120.5M | −11.4% | | 2025-09-30 | 2025-11-10 | −$0.13 | — | $124.7M | −11.9% |
As-reported XBRL · next 2026-11-11 est.ⓘ Segment mixFY2025 (ended Dec 2025) Retail 68% · Third Party Wholesale 32% product & service · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
